|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication February 9, 2007.
Revised April 24, 2007.
Accepted for publication May 7, 2007.
Bradykinin produced at sites of tissue injury and inflammation elicits acute pain and alters the sensitivity of nociceptive neurons to subsequent stimuli. We tested the hypothesis that bradykinin could elicit long lasting changes in nociceptor function by activating members of the Nuclear Factor of Activated T-cells (NFAT) family of transcription factors. Bradykinin activation of B2 receptors evoked concentration dependent (EC50 = 6.0 ± 0.3 nM) increases in intracellular Ca2+ concentration ([Ca2+]i) in a proportion of dorsal root ganglion (DRG) neurons in primary culture. These [Ca2+]i increases were sensitive to inhibition of phospholipase C (PLC) and depletion of Ca2+ stores. In neurons expressing a green fluorescent protein (GFP)-NFAT4 fusion protein, a two minute exposure to bradykinin induced the translocation of GFP-NFAT4 from the cytoplasm to the nucleus. Translocation was partially inhibited by removal of extracellular Ca2+ and was blocked by inhibition of calcineurin. Furthermore, bradykinin triggered a concentration-dependent increase in NFAT-mediated transcription of a luciferase gene reporter (EC50 = 24.2 ± 0.1 nM). This depended on the B2 receptor, PLC activation and IP3 mediated Ca2+ release. Transcription was not inhibited by capsazepine. Lastly, as indicated by quantitative RT-PCR, bradykinin elicited an increase in cyclooxygenase (cox-2) mRNA. This increase was sensitive to calcineurin and B2 receptor inhibition. These findings suggest a mechanism by which short-lived bradykinin-mediated stimuli can enact lasting changes in nociceptor function and sensitivity.
Key words:
Neuropeptides, Bradykinin, Phospholipase C's, NFAT, Ca imaging, Regulation of gene expression
This article has been cited by other articles:
![]() |
M. Nieves-Cintron, G. C. Amberg, M. F. Navedo, J. D. Molkentin, and L. F. Santana The control of Ca2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension PNAS, October 7, 2008; 105(40): 15623 - 15628. [Abstract] [Full Text] [PDF] |
||||